EDS [Exceed Co] S-8: (Original Filing)

[] [EXCEED COMPANY LTD. 1. Purpose. 2. Definitions. Appreciation Right (a) “ Base Price (b) “ Board (c) “ Change of Control (d) “ (i) Person Outstanding Company Voting Securities provided however the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a “ (A) any acquisition directly from the Company] [[LETTERHEAD OF COUNSEL] Our ref LWP\650698\3984700v1 Direct tel +852 2971 3096 Email lorraine.pao@maplesandcalder.com Exceed Company Ltd. 20 December 2010 Dear Sirs Exceed Company Ltd. Registration Statement Plan We have examined the Registration Statement on Form S-8 to be filed by Exceed Company Ltd., a British Virgin Islands company (the “ Yours faithfully, EX-5.1 3 l41400exv5w1.htm EX-5.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form S-8 (for the registration of 10,000,000 shares of common stock) of Exceed Company Ltd of our report dated April 7, 2010, except for Notes 2.5 and 25 for which the date is October 13, 2010, relating to the consolidated financial] [POWER OF ATTORNEY Form S-8 Registration Statement This Power of Attorney may be executed in multiple counterparts, each of which will be deemed an original with respect to the person executing it. th Chairman and Chief Executive Officer Chief Financial Officer Director Director EX-24.1 5 l41400exv24w1.htm EX-24.1]

By | 2016-03-21T03:16:32+00:00 December 20th, 2010|Categories: Chinese Stocks, EDS, SEC Original|Tags: , , , , , |0 Comments

CTC [IFM Investments] 424B3: (Original Filing)

[TABLE OF CONTENTS SUMMARY 1 THE OFFERING 2 RISK FACTORS 3 16 PRICE RANGE OF OUR ADSS 17 EXCHANGE RATE INFORMATION 17 USE OF PROCEEDS 17 RECENT DEVELOPMENTS 18 EXPENSES OF THIS OFFERING 23 DIVIDEND POLICY 24 OTHER INFORMATION ON THE COMPANY 24 MANAGEMENT 25 PRINCIPAL SHAREHOLDERS 28 SELLING SHAREHOLDERS 30 OUR RELATIONSHIP WITH REALOGY 31 DESCRIPTION OF SHARE CAPITAL]

DANG [E-COMMERCE CHINA DANGDANG] SC 13G: (Original Filing)

[JOINT FILING AGREEMENT Dated: December 20, 2010 S.A.C. CAPITAL ADVISORS, L.P. S.A.C. CAPITAL ADVISORS, INC. STEVEN A. COHEN EX-99.1 2 e6217287b.htm JOINT FILING AGREEMENT] [(Name of Issuer) American Depositary Shares Each representing five (5) Class A Shares of Common Stock Par Value $0.0001 Per Share (Title of Class of Securities) 26833A105 (CUSIP Number) December 8, 2010 (Date of Event which Requires Filing of this Statement) o x o * of 8 Page 1 26833A105 CUSIP No. 13G 2 8 Page 1 NAME OF REPORTING]

By | 2016-03-30T05:35:19+00:00 December 20th, 2010|Categories: Chinese Stocks, DANG, SEC Original|Tags: , , , , , |0 Comments

OSN [Ossen Innovation] EFFECT: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica, sans-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif} .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold} .FormName {font-size: large; font-family: arial, helvetica, sans-serif;]

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[December 17, 2010 405 Fifth Street, NW Gentlemen: 135 South State College Boulevard, Suite 300 | Brea, California 92821 | 714.990.1040 | frazerfrost.com Los Angeles and Visalia, CA | Little Rock and Fayetteville, AR | Raleigh, NC F R AZER FROST, LLP EX-16.1 2 v205591_ex16-1.htm] [NEWS RELEASE Skystar Bio-Pharmaceutical Appoints Crowe Horwath LLP as New Independent Auditor XI’AN, CHINA – December 15, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), To be added to the Company's email distribution for future news releases, please send your request to skystar@grayling.com. About Crowe Horwath About Skystar Bio-Pharmaceutical Company Skystar is a China-based developer and distributor]

By | 2016-03-01T05:34:48+00:00 December 17th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[December 17, 2010 405 Fifth Street, NW Gentlemen: 135 South Statellege Boulevard, Suite 300 | Brea,lifornia 92821 | 714.990.1040 | frazerfrost.com Los Angeles and Visalia, | Little Rock and Fayetteville, AR | Raleigh, NC F R AZER FROST, v205591_ex16-1.htm 2 EX-16.1] [NEWS RELEASEystar Bio-Pharmaceutical Appoints Crowe Horwath New Independent Auditor XIAN, CHINA December 15, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), To beded to thempany's email distribution for future news releases, please send your request toystar@grayling.com.out Crowe Horwathoutystar Bio-Pharmaceuticalmpany]

By | 2016-02-05T03:49:00+00:00 December 17th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SIMO [Silicon Motion Technology] 6-K: (Original Filing)

[Silicon Motion Announces Upcoming Schedule of Events with the Financial Community Taipei, Taiwan—December 17, 2010—Silicon Motion Technology Corporation (NasdaqGS: SIMO), a leading fabless semiconductor company that designs, develops, and markets high-performance, low-power semiconductor solutions for the multimedia consumer electronics market, today announced that it will participate in the following upcoming conferences: The 11 th Nomura @ CES 2011 Thursday, January] [Press Release issued by the Company on December 16, 2010. ILICON OTION ECHNOLOGY ORPORATION S]

By | 2016-03-14T20:13:25+00:00 December 17th, 2010|Categories: Chinese Stocks, SEC Original, SIMO|Tags: , , , , , |0 Comments
Skip to toolbar